You must log in to view this page.

Stoke Therapeutics Inc. – Underwriting Agreements

NASDAQ: STOK
Share price (3/18/26): $31.02
Market cap (3/18/26): $1.835 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

EX-1

from SCHEDULE 13D/A ~5 pages Joint Filing Agreement

12/34/56

EX-1

from SCHEDULE 13D/A ~5 pages Joint Filing Agreement

12/34/56

EX-1

from SCHEDULE 13D/A ~5 pages Joint Filing Agreement

12/34/56

EX-1

from SCHEDULE 13D/A ~1 page Joint Filing Agreement

12/34/56

EX-1.1

from 8-K 37 pages Stoke Therapeutics, Inc. 5,555,557 Shares of Common Stock and Pre-Funded Warrants to Purchase 3,703,730 Shares of Common Stock Underwriting Agreement

12/34/56

EX-1.2

from S-3 46 pages Stoke Therapeutics, Inc. Shares of Common Stock (Par Value $0.0001 Per Share) Controlled Equity Offeringsm Sales Agreement

12/34/56

EX-1

from SC 13G/A ~1 page Joint Filing Statement Pursuant to Rule 13d-1

12/34/56

EX-1.1

from 8-K 41 pages Stoke Therapeutics, Inc. 2,500,000 Shares of Common Stock Underwriting Agreement

12/34/56

EX-1.2

from S-3 46 pages Stoke Therapeutics, Inc. Shares of Common Stock (Par Value $0.0001 Per Share) Controlled Equity Offeringsm Sales Agreement

12/34/56

EX-1

from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1

12/34/56

EX-1

from SC 13G 2 pages Joint Filing Statement Pursuant to Rule 13d-1

12/34/56

EX-1.1

from S-1/A 44 pages Stoke Therapeutics, Inc. [—] Shares of Common Stock Underwriting Agreement

12/34/56

Stoke Therapeutics Inc. – Underwriting Agreements Watch

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

Stoke Therapeutics Inc. – Underwriting Agreements